l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Trimethylamine-N-Oxide (TMAO) as a Rising-Star
Trimethylamine N Oxide (TMAO) as a Rising Star Metabolite: Implications for Human Health Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? l carnitine tmao nature medicine 2013 koeth Gut microbiota metabolism of l carnitine and cardiovascular risk Dietary allicin reduces transformation of JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17




